XML 16 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Operations Statement - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
REVENUE:    
Services $ 122,770 $ 162,974
Product sales 30,877 50,669
Total revenue 153,647 213,643
OPERATING EXPENSES:    
Cost of services, exclusive of depreciation expense shown below 85,294 102,795
Cost of product sales, exclusive of depreciation expense shown below 27,520 41,479
General and administrative expense, exclusive of depreciation expense shown below 11,050 12,674
Depreciation 6,627 6,345
Amortization 220 221
Other (income) expense, net (4) 322
Severance and other charges 0 7,090
OPERATING INCOME 22,940 42,717
Interest expense 3,434 2,403
Income before income tax expense 19,506 40,314
Income tax expense 4,389 9,272
Net income 15,117 31,042
Net income (loss) attributable to non-controlling interest 35 (357)
Net income attributable to Core Laboratories N.V. $ 15,082 $ 31,399
EARNINGS PER SHARE INFORMATION:    
Basic earnings per share attributable to Core Laboratories N.V. (in dollars per share) $ 0.36 $ 0.72
Diluted earnings per share attributable to Core Laboratories N.V. (in dollars per share) 0.35 0.72
Cash dividends per share (in dollars per share) $ 0.55 $ 0.55
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:    
Basic 42,380 43,340
Diluted 42,520 43,466